Overview
Urska Zajc practices practicing medicine in Ljubljana, Slovenia.
Their clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Anthrax Infection, and Campylobacter Infection.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Urska Zajc
Is Urska Zajc a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?
MediFind is an objective health platform that identifies experts based on real-world data. Urska Zajc is classified as an Experienced expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Urska Zajc participate in research or clinical trials?
Yes. Urska Zajc has published 15 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Urska Zajc's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anthrax InfectionZajc isExperienced. Learn about Anthrax Infection.
- Campylobacter InfectionZajc isExperienced. Learn about Campylobacter Infection.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)